Alerts will be sent to your verified email
Verify Email
AUROLAB
|
Auro Laboratories
|
Astonea Labs
|
Sotac Pharmaceutical
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
15.74 % | 14.43 % | -4.85 % |
|
5yr average Equity Multiplier
|
1.68 | 7.23 | 7.05 |
|
5yr Average Asset Turnover Ratio
|
1.03 | 0.87 | 1.3 |
|
5yr Avg Net Profit Margin
|
9.45 % | 2.19 % | 1.45 % |
|
Price to Book
|
3.68 | 0.0 | 0.0 |
|
P/E
|
85.69 | 40.29 | 20.65 |
|
5yr Avg Cash Conversion Cycle
|
34.28 Days | 64.4 Days | 3.3 Days |
|
Inventory Days
|
40.18 Days | 81.88 Days | 36.47 Days |
|
Days Receivable
|
87.78 Days | 101.3 Days | 72.11 Days |
|
Days Payable
|
76.54 Days | 173.44 Days | 136.32 Days |
|
5yr Average Interest Coverage Ratio
|
12.13 | 1.85 | 3.3 |
|
5yr Avg ROCE
|
20.0 % | 14.81 % | 19.17 % |
|
5yr Avg Operating Profit Margin
|
14.46 % | 14.98 % | 7.12 % |
|
5 yr average Debt to Equity
|
0.3 | 3.96 | 2.81 |
|
5yr CAGR Net Profit
|
13.98 % | 72.42 % | 116.49 % |
|
5yr Average Return on Assets
|
9.66 % | 2.07 % | 1.93 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.18 % | n/a | 72.85 % |
|
Share Pledged by Promoters
|
0.0 | n/a | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.19 % | n/a | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | n/a | 0.0 |
|
Auro Laboratories
|
Astonea Labs
|
Sotac Pharmaceutical
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|